Mykhaylo Andreychyn

Mykhaylo Andreychyn

Auto-generated profile, based on publicly available information

Mykhaylo Andreychyn

Тернопільський національний медичний університет імені І. Я. Горбачевського МОЗ України

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
BSBoris Shenkman
Boris Shenkman
IBIvan Budnik
Ivan Budnik
YEYulia Einav
Yulia Einav
HHHagit Hauschner
Hagit Hauschner
MAMykhaylo Andrejchin
Mykhaylo Andrejchin
UMUriel Martinowitz
Uriel Martinowitz
Trauma-induced coagulopathy (TIC) is commonly seen among patients with severe injury. The dynamic process of TIC is characterized by variability of the features of the disease. A model of TIC was created. Hemodilution was produced by mixing the blood with 40% Tris/saline solution, fibrinolysis by treating the blood with 160 ng/mL tPA, acidosis by adding 1.2 mg/mL lactic acid achieving pH 7.0 to 7.1, and hypothermia by running the assay at 31°C. Intact blood tested at 37°C served as control. Clot formation was evaluated using rotation thromboelastometry. Platelet adhesion and aggregation were assayed at a shear rate of 1800 s(-) using Impact-R device. Clotting time was not affected by any of the TIC constituents used. Clotting initiation was reduced by hemodilution and further reduced by additive hypothermia. The propagation phase of blood clotting was reduced by hemodilution, further reduced by additive hypothermia, and maximally reduced if additionally combined with fibrinolysis. No effect of fibrinolysis on clot propagation was observed at 37°C. Maximum clot firmness was reduced by hemodilution, further reduced by additive fibrinolysis, and maximally reduced if additionally combined with hypothermia. No effect of hypothermia on clot strength was observed in the absence of fibrinolysis. Platelet adhesion (percentage of surface coverage) and aggregation (aggregate size) under flow condition were reduced by hemodilution and further reduced by additive acidosis. Introduction of tPA to diluted blood had no effect on platelet function. The study revealed a differential effect of TIC constituents-hemodilution, hypothermia, fibrinolysis, and acidosis-on clot formation and platelet function. The effect of one factor may influence that of another factor. These data may be helpful to better understand the pathogenesis of TIC and to elaborate an individually tailored treatment strategy. A new model of TIC is created. Contribution of various constituents to pathogenesis of TIC and their interactions are evaluated.

11 August 2020 in Інфекційні хвороби
Verified
Journal Article
Open access
PDF file
MAM. A. Andreychyn
M. A. Andreychyn
NNN. A. Nychyk
N. A. Nychyk
NZN. H. Zavidniuk
N. H. Zavidniuk
IIIaryna Iosyk
Iaryna Iosyk
III. S. Ischuk
I. S. Ischuk
OIO. L. Ivakhiv
O. L. Ivakhiv
На підставі огляду наукової літератури наведено основні дані про історію коронавірусних інфекцій людини, зокрема епідемії тяжкого гострого респіраторного синдрому (SARS) і близько-східного респіраторного синдрому (MERS) та теперішню пандемію COVID-19. Послідовно описано етіологію COVID-19, її епідеміологію, патогенез, основні клінічні варіанти та їх прояви, класифікацію за ступенем тяжкості, можливі ускладнення та обтяжливі чинники. Подано визначення різних випадків цієї інфекції за епідеміологічними та клінічними критеріями. Перечислено лабораторні та апаратні методи діагностики з клінічним тлумаченням. Виокремлено методи специфічної та диференційної діагностики. Наведено показання до госпіталізації хворих на COVID-19 і сучасні підходи до лікування за відсутності специфічних противірусних засобів. У лікуванні акцент зроблено на застосуванні патогенетичної терапії. Стисло наведено основні заходи неспецифічної індивідуальної та колективної профілактики із запровадженням карантину. Стаття призначена головно для лікарів, які працюють з хворими на COVID-19 і контактними особами.

1 September 2018 in Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
MWMarcin Piotr Weiner
Marcin Piotr Weiner
WŻWioletta Żukiewicz-Sobczak
Wioletta Żukiewicz-Sobczak
MTMałgorzata Tokarska-Rodak
Małgorzata Tokarska-Rodak
DPDorota Plewik
Dorota Plewik
APAnna Pańczuk
Anna Pańczuk
MPMariana Pavliuk
Mariana Pavliuk
Introduction: Lyme borreliosis/Lyme disease is caused by Borrelia burgdorferi and is one of the most common vector-borne diseases transmitted by ticks. Material and Methods: A total of 136 Ixodes ricinus ticks, collected in the Ternopil (Ukraine) region, including 126 adults (70 females and 56 males), and 10 nymphs were examined. The identification of the species and their developmental form was based on morphological characteristics. Results: PCR with B5S-Bor and 23S-Bor primers resulted in Borrelia burgdorferi sensu lato DNA amplification among six ticks (4.4%). The detailed analysis based on the DNA sequencing showed the presence of DNA of Borrelia afzelii in four samples; the remaining two represented Borrelia burgdorferi sensu lato complex, although their genospecies were not determined. The research confirmed the dominance of Borrelia afzelii genospecies in the ticks from Ukraine. Conclusion: It seems reasonable to undertake similar research in ticks from other regions of Ukraine. Knowledge in this field can be useful for public health and planning the prevention of tick-borne diseases.

21 October 2019 in Healthcare
Verified
Journal Article
Open access
PDF file
JSJyotsna Jyotsna Shah
Jyotsna Jyotsna Shah
SLSong Liu
Song Liu
ICIris Du Cruz
Iris Du Cruz
APAkhila Poruri
Akhila Poruri
RMRajan Maynard
Rajan Maynard
Ranjan RamasamyRanjan Ramasamy
Ranjan Ramasamy
Tick-borne relapsing fever (TBRF) is caused by spirochete bacteria of the genus Borrelia termed relapsing fever Borreliae (RFB). TBRF shares symptoms with Lyme disease (LD) caused by related Lyme disease Borreliae (LDB). TBRF and LD are transmitted by ticks and occur in overlapping localities worldwide. Serological detection of antibodies used for laboratory confirmation of LD is not established for TBRF. A line immunoblot assay using recombinant proteins from different RFB species, termed TBRF IB, was developed and its diagnostic utility investigated. The TBRF IBs were able to differentiate between antibodies to RFB and LDB and had estimated sensitivity, specificity, and positive and negative predictive values of 70.5%, 99.5%, 97.3%, and 93.4%, respectively, based on results with reference sera from patients known to be positive and negative for TBRF. The use of TBRF IBs and analogous immunoblots for LD to test sera of patients from Australia, Ukraine, and the USA with LD symptoms revealed infection with TBRF alone, LD alone, and both TBRF and LD. Diagnosis by clinical criteria alone can, therefore, underestimate the incidence of TBRF. TBRF IBs will be useful for laboratory confirmation of TBRF and understanding its epidemiology worldwide.

19 May 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NMNataliia Melnichuk
Nataliia Melnichuk
Vladimir V. ZarubaevVladimir V. Zarubaev
Vladimir V. Zarubaev
IIIaryna Iosyk
Iaryna Iosyk
MAMychaylo Andreychyn
Mychaylo Andreychyn
LSLarisa Semernikova
Larisa Semernikova
ZTZenoviy Tkachuk
Zenoviy Tkachuk
Oligoribonucleotides-D-mannitol (ORNs-D-M) complexes possess antiviral, anti-inflammatory, and immunomodulatory actions. The aim of the present study was to evaluated an antiviral effect of ORNs-D-M against parainfluenza virus type 3 (PIV3); influenza CA709, PR834; avian influenza virus H5N2 (AIV) in vitro by a TCID50; hemadsorption and neuraminidase activity assays; and clinical efficiency of ORNs-D-M in patients with acute respiratory infections (ARIs) of various etiologies by PCR assay and AmpliSens test systems. It was observed that ORNs-D-M have an antiviral activity against the influenza CA709, PR834, PIV3, and AIV in vitro. The injectable dosage form of ORNs-D-M was shown to have a stronger antiviral effect compared to capsule form. It was also detected that the injectable form of ORNs-D-M significantly reduced the neuraminidase activity of influenza PR834. A complex treatment of patients with ORNs-D-M had a positive effect on the course of the disease, it accelerated patients’ recovery. Treatment with ORNs-D-M caused eradication of adeno- and influenza viruses in patients with ARI. This drug contributed to significant decrease in duration of febrile period and cough. Comprehensive treatment with ORNs-D-M improved the disease clinical findings significantly. Collectively, these results suggested that ORNs-D-M may be used at co-infection with influenza and other respiratory viruses as a medical antiviral drug.

23 December 2017 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
NVNatalia Vasylieva
Natalia Vasylieva
MAMykhaylo Andreychyn
Mykhaylo Andreychyn
YKYulia Kravchuk
Yulia Kravchuk
ОCОlena Chervinska
Оlena Chervinska
IIIaryna Iosyk
Iaryna Iosyk
Introduction: Leptospirosis is endemic in Ternopil region. In Ukraine, the disease is registered in almost all regions, including the Ternopil region. The aim of the research is to study the regularities of epidemic and epizootic processes of leptospirosis, and the circulation of its pathogens...